Clinical and pathologic prognostic features of leiomyosarcoma of the uterus.
A clinico-pathologic study of 20 consecutive patients with leiomyosarcoma of the uterus seen over a 12-year period has been evaluated. Tumor extent at the time of diagnosis seems to be the main prognostic factor: 62.5% of the patients in stage I are alive and well from 1 to 7 years after the diagnosis as compared to 0% of the patients in all the other stages. The age of the patients and the number of mitotic figures also appear to have some prognostic value.
D000328:Adult; D000367:Age Factors; D000368:Aged; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007890:Leiomyosarcoma / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D011379:Prognosis; D014594:Uterine Neoplasms / Q000473:pathology* / Q000601:surgery